Why the markets are freaking out about Chinese AI newcomer DeepSeek – Go Health Pro

Why the markets are freaking out about Chinese AI newcomer DeepSeek – Go Health Pro

Chinese tech champion Huawei has emerged as Nvidia’s primary competitor in China for inference chips. The Financial Times has previously reported that it has been working with AI companies, including DeepSeek, to adapt models trained on Nvidia GPUs to run inference on its Ascend chips. “Huawei is getting better. They have an opening as the … Read more

Indian jewellers build on diaspora to break into western markets – Go Health Pro

Indian jewellers build on diaspora to break into western markets – Go Health Pro

When Viren Bhagat announced plans to set up shop in London, he joined a growing number of Indian jewellers expanding into western markets, where the vast majority of the country’s diaspora live. Bhagat started to increase his exposure outside India through his participation in Tefaf, the European Fine Art Foundation fair held annually in Maastricht … Read more

Hannover Re makes Jaramillo Associate Underwriter in Capital Markets & ILS team – Go Health Pro

Hannover Re makes Jaramillo Associate Underwriter in Capital Markets & ILS team – Go Health Pro

Global reinsurer Hannover Re has appointed Angela Jaramillo as an Associate Underwriter within its Capital Markets and insurance-linked securities (ILS) team.Jaramillo, has been with the reinsurer since 2021, having most recently served as an Associate Underwriter for the company’s property and casualty (P&C) Treaty Underwriting team for Latin America, Spain and Portugal. In addition, Jaramillo … Read more

Zacks Small Cap Research – OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR – Go Health Pro

NASDAQ:GRCE | NASDAQ:ACST Since the recording of this interview, the company has changed its name to Grace Therapeutics and is now trading under NASDAQ:GRCE. John Viglotti: Hello, and welcome to Virtual Investor Conferences. My name’s John Viglotti, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you joined … Read more

Zacks Small Cap Research – OTC Markets Hosts Virtual Investor Presentation with Dror Bashan, President & CEO of Protalix Biotherapeutics, and John Vandermosten, Senior Analyst at Zacks SCR – Go Health Pro

NYSE:PLX John Viglotti: Hello, and welcome to Virtual Investor Conferences. My name is John Viglotti, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you joined us for our next presentation from Protalix Biotherapeutics. Their session will be moderated by John Vandermosten. He’s the Senior Biotechnology Analyst with … Read more